Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've heard they will publish preclinical data sometime this half (SITC?) and they might file an IND as well.
Been very quiet no news..
EDIT is making a nice run without news. Looks like a healthy development and presumably indicates that investors expect positive results in the LCA-10 trial. Stock appears very cheap compared to the potential of this technology. August calls are being bought today as well!
I suspect that one or more newsletters are pushing this stock.
Nice 9% gain today after news of dosing 1st patient with LCA. News of dramatic break through in medicine finally reaching investors?
Yeah they have the new editing method correct? CAS-9? Forgive me this science is above my head but I understand the value and significance of the breakthrough technology. Very interesting science.
IT opened last week. Price fell on day one but has been recovering since. Good time to buy IMO.
I didn’t think it had been listed yet...
Yes, I bought in on the IPO day. A lot of potential in this and other gene editing companies.
Has anyone been watching Beam Therapeutics? They filed for an IPO in September. They are spearheading the second generation gene editing therapies with Prime Medicine. It looks very promising!
Editas keeps moving up. Investors expecting BIG NEWS soon IMO. Trials underway . We’ll just wait and see. I’m buying calls and holding shares.
Hey Chico, now I think you were right. There is no longer CELG listed. It was bought out by BMY. I don’t know what happened to CELGZ. I owned a few shares and now I have an untradable number of shares in something else.
U were right. Sorry for the doubt
No they bought Celgene. I own the stock you said. It is doing business with editas. I wish they would of bought my stock
Bristol bought a small spin off company, CELGZ. It was worth about 0.50 but yeah there is a lot of interest in buying small biotech. Editas could be a buyout candidate or could make it big on their products now in trials.
Did you see where Bristol Meyers squib bought Celgene. I hope this is a 10 baggers
I agree. Looking forward to a big year.
STOCK OF THE YEAR for 2020? Some are expecting big things from this gene editing company. Collaborations with Allergan, Celgene, Juno. A promising pipeline. I am surprised that this message board is dead.
On sale today. Oversold on news.
Sell off is here. Earnings less than previous quarter. Insiders sell. I took a short Position. https://www.google.com/amp/s/www.fairfieldcurrent.com/2018/11/06/editas-medicine-inc-edit-insider-katrine-bosley-sells-12000-shares.html/amp
I knew I should have bought Wednesday on the dip. Shouldn't have waited. Then again, it probably won't matter in a year. I expect this to be much higher. Amazing that no one has posted here in two months. Is everyone distracted by #RSP because they have Crispr in their name?
Anyone buying EDIT or is it going lower?
What's going on in this industry? Edit is down, Crsp is down, and my stop loss on NTLA just triggered!
If the insiders don't sell, the price can go up much faster!
It won't cool off. Looking at it goes above $60!
Exactly, all these gene editing companies needed to cool off. They will soon take off to insane levels.
Yes sir.we will be watching
Next week will be interesting! don't miss out buddy!
Just riding the wave$EDIT$
It would be nice if we gain another 10% today! Bingo!
we are all happy making a 10% gain in one day. The target price is $67 as per Morgan Stanley
reporting earnings on tuesday
reporting earnings on tuesday
That’s a big number. Just got into this stock recently. We shall see.
im hoping for 100% around 80
I think this will hit mid 40’s maybe higher
what price do you think it will hit?
Looks like wash trades happening here
President & CEO bailing put ?
Good news ?
Is this the company being hyped as the "God Key" that all of the worlds billionaires are throwing money at?
They have license agreements with JUNO $48.75 and ADVM $3.95
Followers
|
43
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
146
|
Created
|
02/02/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |